SCHEMBL6605732

SCHEMBL6605732

CCc1oc(-c2ccc(F)cc2)nc1CC(=O)O

nearest known ligand 0.52

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.52
PPARG P37231 5/20 0.47
PPARA Q07869 5/20 0.47
PPARD Q03181 1/20 0.47
RAB9A P51151 1/20 0.43
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
LMNA P02545 1/20 0.42
TARBP2 Q15633 1/20 0.41
TP53 P04637 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
PDE4B Q07343 1/20 0.40
PDE4D Q08499 1/20 0.40
ADCY1 Q08828 1/20 0.40
MAPT P10636 1/20 0.40
PTGDR2 Q9Y5Y4 1/20 0.40
ALDH1A1 P00352 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11010422 0.85 KDM4E (0.49) KDM4EPPARGPPARAPPARDLMNA
SCHEMBL4030027 0.83 KDM4E (0.76) KDM4EPPARGPPARAPPARDRAB9A
SCHEMBL13115729 0.82 KDM4E (0.54) KDM4EPPARGPPARAPPARDRAB9A
SCHEMBL6604396 0.82 MEN1 (0.43) KDM4EPPARGPPARAPPARDRAB9A
SCHEMBL6608776 0.80 PPARG (0.42) PPARGPPARAPPARDRAB9AMEN1
SCHEMBL6602803 0.80 TARBP2 (0.52) PPARGPPARAPPARDMEN1KMT2A
SCHEMBL11008810 0.80 KDM4E (0.51) KDM4EPPARGPPARAPPARDLMNA
SCHEMBL13115484 0.79 KDM4E (0.61) KDM4EPPARGPPARAKMT2ALMNA
SCHEMBL6607542 0.78 PPARG (0.46) PPARGPPARAPPARDRAB9AMEN1
SCHEMBL2818553 0.77 TP53 (0.49) KDM4ERAB9ALMNATP53SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1102757-B1 SUBSTITUTED OXAZOLE AND THIAZOLE DERIVATIVES AS HPPAR GAMMA AND HPPAR ALPHA ACTIVATORS GLAXO GROUP LTD (GB) 2004-04-14 EP disclosed
US-6498174-B1 AGONISTS TO PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; MODULATING BLOOD GLUCOSE AND LIPID LEVELS; REDUCING DYSLIPIDEMIA AND HYPERINSULINEMIA ASSOCIATED WITH IMPAIRED GLUCOSE TOLERANCE OR METABOLIC SYNDROME SMITHKLINE BEECHAM CORPORATION 2002-12-24 US disclosed